Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 29, 2025, Actinium Pharmaceuticals (ATNM) has a market cap of $44.610 million USD. According to our data, Actinium Pharmaceuticals is ranked No.8179 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 29, 2025 | $44.61 M |
13.49%
|
| Dec 31, 2024 | $39.31 M |
-75.20%
|
| Dec 29, 2023 | $0.16 B |
-52.30%
|
| Dec 30, 2022 | $0.33 B |
77.20%
|
| Dec 31, 2021 | $0.19 B |
-22.95%
|
| Dec 31, 2020 | $0.24 B |
19.27%
|
| Dec 31, 2019 | $0.20 B |
-43.67%
|
| Dec 31, 2018 | $0.36 B |
-41.72%
|
| Dec 29, 2017 | $0.62 B |
-24.11%
|
| Dec 30, 2016 | $0.82 B |
-72.91%
|
| Dec 31, 2015 | $3.02 B |
-45.16%
|
| Dec 31, 2014 | $5.51 B |
0.00%
|
| Dec 31, 2013 | $5.51 B |
292.67%
|
| Dec 31, 2012 | $1.40 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 BioNTech
BNTX
|
$25.00 B |
0.001 M
|
Germany
|
 Moderna
MRNA
|
$10.76 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
USA
|
 Amgen
AMGN
|
$152.20 B |
0.126 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
USA
|
 Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
USA
|
 Merck
MRK
|
$212.01 B |
-0.001 M
|
USA
|
 Pfizer
PFE
|
$130.73 B |
-0.001 M
|
USA
|
 Novartis
NVS
|
$224.23 B |
0.160 B
|
Switzerland
|
 AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
UK
|
 Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
USA
|
 Sanofi
SNY
|
$128.86 B |
0.003 M
|
France
|
| Market Cap | = | ATNM Stock Price | * | ATNM Shares Outstanding |
| = | $1.43 | * | 31.20 M | |
| = | $44.61 M |